News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ParagonDx Forms Partnership with Iverson Genetic Diagnostics



4/8/2008 9:38:27 AM

MORRISVILLE, N.C.--(BUSINESS WIRE)--ParagonDx, LLC, a leader in genetic testing diagnostics, has formed a strategic alliance with Iverson Genetic Diagnostics Inc., a Clinical Laboratory Improvement Amendments (CLIA) certified laboratory based in Seattle. Under the terms of the agreement, Iverson Genetics will use ParagonDx’s products to test patients to determine if they possess genetic traits shown to increase or decrease sensitivity to warfarin. Warfarin is a blood thinner that prevents and treats blood clots and is also known as Coumadin.

Read at BioSpace.com


comments powered by Disqus
ParagonDx
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES